Recent Company News

• 06:23 AM ET Aug 14, 2025
  

  StreetAccount Summary - European unusual volume traders

• 04:03 PM ET Jul 29, 2025
  

  Inventiva reports H1 revenue €4.5M vs year-ago €0.0M (€2.90, 0.00)

• 04:11 PM ET Jul 09, 2025
  

  Inventiva names Jason Campagna as President of R&D and Chief Medical Officer (€2.77, 0.00)

• 04:23 AM ET Jul 08, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 04:04 PM ET Jul 02, 2025
  

  Inventiva announces results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH in the Journal of Hepatology (€2.57, 0.00)

• 08:53 AM ET Jun 27, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 02:39 AM ET May 23, 2025
  

  Inventiva Q1 update: available cash and cash equivalents to fund its operations as currently planned until end of Q3 2026; will need to raise additional funds to achieve its long-term objectives (€2.80, 0.00)

• 02:43 AM ET May 05, 2025
  

  Inventiva secures the €116M second tranche of its structured financing of up to €348M (€3.24, 0.00)

• 04:15 PM ET Apr 24, 2025
  

  Inventiva announces publication in Clinical Gastroenterology and Hepatology (€3.16, 0.00)

• 10:09 AM ET Apr 22, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (36 total)